Remove 2008 Remove IPO Remove Mergers and Acquisitions
article thumbnail

Highlights from Cooley’s M&A Dealmakers Roundtable: SPACs!

Cooley M&A

starting in the early 2000s and ending around the start of the 2008-2009 financial crisis, and the second (SPAC 2.0) is the increased frequency at which SPAC IPOs are occurring. There are currently very few people in the IPO ecosystem that don’t recognize the value of a SPAC as an alternative to a traditional IPO or a direct listing.

M&A 52
article thumbnail

Growth Equity: The Child Prodigy of Private Equity and Venture Capital, or an Artifact of Easy Money?

Mergers and Inquisitions

Others would counter that growth equity’s rapid ascent was mostly due to the easy money that persisted between 2008 and 2021. This style is about purchasing minority stakes in cash-flow-negative-but-high-growth companies that want to scale and eventually go public or sell (think: Uber or Airbnb before their IPOs).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How do Banks Make Money? Explanation, Examples

Peak Frameworks

When Facebook went public in 2012, it needed an investment bank to handle the Initial Public Offering (IPO). Goldman Sachs was one of the lead underwriters and earned considerable fees and reputation points for facilitating one of the largest tech IPOs ever. Many banks had extended loans to customers who couldn’t pay them back.

Bank 52
article thumbnail

Bulge Bracket Banks: 2024 Edition

Mergers and Inquisitions

But the events of 2023, including the UBS acquisition of Credit Suisse and the rise of firms like Wells Fargo, Jefferies, and RBC, have shaken up the traditional list. The name “bulge bracket” (BB) comes from the prospectus for an IPO or debt issuance, which lists all the banks underwriting the deal.

article thumbnail

Top 10 Cross-Border M&A Trends across the Pond

Cooley M&A

government shutdown disrupting the market for IPOs, Brexit uncertainty, natural disasters and various other crises, cross-border M&A activity momentum continues. New records were attained in the past twelve months, eclipsing the previous highs set pre-2008 financial crash. In the U.S., There is no indication that U.S.

M&A 52
article thumbnail

Cooley’s 2021 Life Sciences M&A Year in Review

Cooley M&A

1] Major all-cash acquisitions have followed, such as Arena Pharmaceutical’s agreement to sell to Pfizer for $6.7 Midsize pharmaceutical buyers pursuing opportunistic acquisition strategies, with robust capital markets and high valuations having limited the pool of attractive assets available in recent years.

M&A 40